NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.63
+27.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 117.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.55x
- Price / sales
- 1761.48x
- Price / cash flow
- -6.66x
Enterprise value
- Enterprise value
- $278.5M
- EV / sales
- 1465.61x
- EV / EBITDA
- -5.18x
- EV / EBIT
- -4.44x
- Market cap
- $334.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026